DV
Dividend Vision

PRVA Stock — Privia Health Group, Inc.

Privia Health Group, Inc. (PRVA)

Updated October 16, 2026.

PRVA is a Stock. Total return is -2.1% over the past 5.5 years, 98.9 points behind SPY at 96.8%.

Privia Health Group operates as a physician-enablement company in the United States, providing technology platforms, practice management services, and population health tools to help physician practices, health systems, and health plans improve clinical and financial outcomes. The company facilitates value-based care through accountable care organizations and networks that enable providers to better coordinate patient care and reduce administrative burdens. Privia does not currently have an established distribution schedule.

PRVA performance versus SPY

Price and return data through 2026-10-16.

Total return is -2.1% over the past 5.5 years, 98.9 points behind SPY at 96.8%. Over the past year its total return — price change plus distributions reinvested — is -11.8%. Its deepest 1-year drawdown was 32.0%.

WindowTotal returnCAGR
1M10.6%—
3M-17.3%—
6M-4.2%—
YTD-5.0%—
1Y-11.8%—
2Y CAGR—11.50%
3Y CAGR—0.90%
5Y CAGR—-0.90%
Since inception (5.5 years)-2.1%-0.40%

PRVA key facts

Asset type
Stock
Asset class
Equity
Inception date
04/28/2021
Distribution frequency
None
Last close
$22.52 (as of 2026-10-16)
Market cap
$2,876,574,342
Average volume
1247557.0
Beta
0.802
Payout ratio
0.0%
P/E ratio
112.6
Forward P/E
17.2712
EPS
$0.20

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PRVA risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 32.0%.

Who may consider PRVA — and who may not

It is a weaker fit for investors who need monthly cash flow (PRVA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PRVA

Tagged: Healthcare.

Frequently asked questions

Does PRVA pay monthly?

No. PRVA does not currently distribute.

When does PRVA pay a dividend?

PRVA does not currently distribute.

How has PRVA performed?

Total return is -2.1% over the past 5.5 years, 98.9 points behind SPY at 96.8%. Over the past year its total return — price change plus distributions reinvested — is -11.8%. Its deepest 1-year drawdown was 32.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.